US

Ulrich Sensfuss

NA Novo Nordisk A/S: 9 patents #151 of 1,775Top 9%
Overall (All Time): #562,342 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
10570184 GLP-1/glucagon receptor co-agonists for medical use Jesper Lau, Thomas Kruse 2020-02-25
9988430 Stable GLP-1 based GLP-1/glucagon receptor co-agonists Steffen Reedtz-Runge, Thomas Kruse, Jane Spetzler, Henning Thoegersen, Christian Wenzel Tornoee +1 more 2018-06-05
9751927 Stable, protracted GLP-1/glucagon receptor co-agonists for medical use Thomas Kruse, Jesper Lau 2017-09-05
9486505 Glucagon analogues Jesper Lau, Thomas Kruse, Henning Thoegersen, Peter Kresten Nielsen 2016-11-08
9486506 Glucagon analogues Jesper Lau, Thomas Kruse, Henning Thoegersen, Peter Kresten Nielsen 2016-11-08
9474790 Stable, protracted GLP-1/glucagon receptor co-agonists for medical use Thomas Kruse, Jesper Lau 2016-10-25
8541368 Glucagon analogues Jesper Lau, Thomas Kruse, Henning Thoegersen, Peter Kresten Nielsen 2013-09-24
7541430 Peptides for use in treating obesity Kilian Waldemar Conde Frieboes, Leif Christensen, Ingrid Vivika Petterson, Thomas Kruse Hansen, Michael Ankersen +1 more 2009-06-02
7517854 Melanocortin receptor agonists Kilian Waldemar Conde-Frieboes, Kjeld Madsen, Nils Langeland Johansen, Leif Christensen, Thomas Kruse Hansen +1 more 2009-04-14